-- 根據週一台灣證券交易所發布的消息，Applied BioCode（股票代號：TPE:6598）的美國子公司已獲得美國FDA的510(k)上市許可，其呼吸道病原體檢測板已獲批准。 該許可證允許該檢測板與BioCode MDx 3000系統以及賽默飛世爾科技的KingFisher萃取平台配合使用，進一步擴展了其與生物梅里埃和羅氏系統的兼容性。 該公司表示，此次獲批將使其能夠在美國銷售該組合解決方案，為實驗室提供更靈活的萃取系統選擇，並有望提升其業務和財務表現。
Related Articles
Asia
Market Chatter: Coles CEO Says Grocery Price Increases 'Inevitable' Amid Fuel Cost Surge
Coles Group (ASX:COL) Chief Executive Leah Weckert said price hikes for groceries are "inevitable" as the supermarket chain and its suppliers deal with higher fuel costs, Bloomberg reported Monday.Speaking at an Australian Shareholders' Association conference in Melbourne, Weckert said that the trend is showing up in supermarket data, with shoppers opting for beef mince or chicken over steak, while also making fewer trips to stores to cut fuel costs.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:COL
Asia
Singapore Airlines to Deploy Starlink Broadband Services in 2027
Singapore Airlines (SGX:C6L) will deploy Starlink's low-earth-orbit satellite-based broadband service on its planes, starting from the first quarter of 2027, according to a company release on Monday.The service will be available to all cabin classes on Starlink-enabled aircraft.
$SGX:C6L
Asia
iX Biopharma Secures Listing and Quotation Notice for New Shares; Shares Zoom 11%
iX Biopharma (SGX:42C) received a listing and quotation notice from the Singapore Exchange Securities Trading for 1.3 million shares, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical and nutraceutical company surged nearly 11% in Monday trading.The notice is subject to shareholder approval and compliance with the bourse's listing requirements, the filing added.
$SGX:42C